Rakovina Therapeutics Inc. | Finanzwire

Basculer en Français

10097	Companies
206740	Keywords
136884	Articles
109570	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 04/02/2025 at 15:36, 11 months 23 days ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
PRESS RELEASE

published on 04/02/2025 at 15:31, 11 months 23 days ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 03/26/2026 at 13:00, 48 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 48 minutes ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 49 minutes ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 1 hour 3 minutes ago

Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 1 hour 3 minutes ago

Electric Royalties Provides Update on Critical Metals Royalty Portfolio

View all ACCESSWIRE

EQS Group

Published on 03/26/2026 at 13:00, 48 minutes ago

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 03/26/2026 at 13:00, 48 minutes ago

Nebius AI Cloud 3.5 introduces serverless AI to give developers frictionless compute for real-world AI
Published on 03/26/2026 at 12:45, 1 hour 3 minutes ago

Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 1 hour 28 minutes ago

North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 1 hour 31 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

Les Echos

Published on 03/26/2026 at 08:57, 4 hours 51 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 6 hours 18 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 18 hours 55 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 19 hours 17 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 20 hours 3 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE